Skip to content
Amsterdam institute for Immunology and Infectious diseases
Research institutes

Amsterdam institute for Immunology and Infectious diseases

AI&I news

  • VACCINATION IMPACT | Advancing Hepatitis C Vaccine Research at AI&I
    VACCINATION IMPACT | Advancing Hepatitis C Vaccine Research at AI&I At the Amsterdam Institute for Immunology and Infectious Diseases (AI&I), vaccination is one of three key research pillars, alongside PAIS and Immunomonitoring. Regularly, we highlight one of these areas, exploring essential knowledge, challenges, and real-world impact. In Q3 2026, our focus is on Vaccination. In collaboration with AI&I researcher Dr. Kwinten Sliepen, we share the story of how vaccination research at AI&I is making a difference.
  • Diagnosing sepsis: reducing the three-day wait
    Diagnosing sepsis: reducing the three-day wait When a patient is admitted with suspected sepsis, doctors start antibiotics immediately, but for up to three days, they do not know exactly which microbe they are fighting. Today, in the final article of our series ahead of World Sepsis Day on 13 September, Dr. Iedan Verly explains how innovative diagnostics aim to shorten that delay and how the research done within his department contributes to these new tools.
  • Treating sepsis: act fast and know when to stop
    Treating sepsis: act fast and know when to stop Sepsis is a medical emergency, but once the acute crisis is over, the question changes: how much treatment does this patient still need? Today, in the second article of our series ahead of World Sepsis Day on 13 September, Dr. Kim Sigaloff outlines why the smartest course of antibiotics may be the shortest one that is still safe.

Submit your newsitem

Subscribe to our Newsletter

Sign up
Archive
Subscribe to our Newsletter

All news from Amsterdam institute for Immunology and Infectious Diseases

One PURE-system for all of Amsterdam UMC
Internship platform is live!
AI&I Researchers Secure €6.5 Million in ZonMw Grants for Post-COVID Research
New Centers of expertise for Post-COVID Patients: Three Specialized Clinics Opened on November 1
Valorization Compass to Increase Societal Impact
Vidi Grants Awarded to Three Researchers from the Amsterdam Institute for Immunology and Infectious diseases
In the Spotlight October 2024: AI&I Prizes, Grants, and Appointments
Data & AI symposium on December 9: drivers of innovation in Amsterdam UMC
Progress and Challenges in HIV Care for Transgender Women in the Netherlands: Insights from an 11-Year Study
Marburg virus: How dangerous is this bat-borne disease?
Hans van Goudoever on the new strategy: 'The shutters are opening'
Completion Research & Diagnostics Center Adore important milestone for Amsterdam UMC
Adore: €9 Million Grant from Dutch Research Council (NWO) and ‘The Largest Bingo Ever’
INFECT-NL: Better Prepared for Infectious Diseases with Human Challenge Models
In the Spotlight September 2024: AI&I Prizes, Grants, and Appointments
New PURE Amsterdam UMC: PURE AMC and PURE VUmc freeze
Amsterdam Cohort Hub webinars are coming up!
Amsterdam UMC Launches New Female Talent Program
Research Network Relaunched as Human Research Network
First joint symposium between Amsterdam Public Health and Amsterdam Institute for Immunology and Infectious diseases
Immunologists Aim to Prevent the Next Pandemic by Preemptively Neutralizing Viruses
Experts Advocate for Vaccination Program as WHO Warns of Dangerous New Mpox Variant
Practical sustainable project idea? Make use of the Green Fund!
7th Annual Symposium: AI in AI&I
Findings survey Recognition & Rewards: academic staff would like more room for individual talent
In the Spotlight July 2024: AII Prizes, Grants, and Appointments
Immunity from Prior SARS-CoV-2 Infection Against Seasonal Coronaviruses
Transfer of IgG from Long COVID patients induces symptomology in mice
New grants available for interdisciplinary Midsize Projects, up to €200k
Peak Tick Season Hits, but Lyme Diseases Vaccine is Coming Closer

Submit your newsitem